Contraception
Volume 64, Issue 4 , Pages 227-234, October 2001

On the mechanisms of action of short-term levonorgestrel administration in emergency contraception

  • Marta Durand

      Affiliations

    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
  • ,
  • Ma del Carmen Cravioto

      Affiliations

    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
  • ,
  • Elizabeth G Raymond

      Affiliations

    • Family Health International, Research Triangle Park, NC, USA
  • ,
  • Ofelia Durán-Sánchez

      Affiliations

    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
  • ,
  • Ma De la Luz Cruz-Hinojosa

      Affiliations

    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
  • ,
  • Andrés Castell-Rodrı́guez

      Affiliations

    • Department of Cellular Biology, School of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico
  • ,
  • Raffaela Schiavon

      Affiliations

    • Reproductive Health Service, Instituto Nacional de Pediatrı́a, Mexico City, Mexico
  • ,
  • Fernando Larrea

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +525-573-11-60; fax: +525-655-98-59
    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Abstract 

The effects of short-term administration of levonorgestrel (LNG) at different stages of the ovarian cycle on the pituitary-ovarian axis, corpus luteum function, and endometrium were investigated. Forty-five surgically sterilized women were studied during two menstrual cycles. In the second cycle, each women received two doses of 0.75 mg LNG taken 12 h apart on day 10 of the cycle (Group A), at the time of serum luteinizing hormone (LH) surge (Group B), 48 h after positive detection of urinary LH (Group C), or late follicular phase (Group D). In both cycles, transvaginal ultrasound and serum LH were performed from the detection of urinary LH until ovulation. Serum estradiol (E2) and progesterone (P4) were measured during the complete luteal phase. In addition, an endometrial biopsy was taken at day LH + 9. Eighty percent of participants in Group A were anovulatory, the remaining (three participants) presented significant shortness of the luteal phase with notably lower luteal P4 serum concentrations. In Groups B and C, no significant differences on either cycle length or luteal P4 and E2 serum concentrations were observed between the untreated and treated cycles. Participants in Group D had normal cycle length but significantly lower luteal P4 serum concentrations. Endometrial histology was normal in all ovulatory-treated cycles. It is suggested that interference of LNG with the mechanisms initiating the LH preovulatory surge depends on the stage of follicle development. Thus, anovulation results from disrupting the normal development and/or the hormonal activity of the growing follicle only when LNG is given preovulatory. In addition, peri- and post-ovulatory administration of LNG did not impair corpus luteum function or endometrial morphology.

Keywords:  Corpus luteum, Emergency contraception, Levonorgestrel, Mechanism of action, Ovulation, Progestins

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by grants from Family Health International (North Carolina, USA), US Agency for International Development (Washington, DC, USA), the Andrew W. Mellon Foundation (New York, USA), and El Consejo Nacional de Ciencia y Tecnologı́a (Mexico).

PII: S0010-7824(01)00250-5

Contraception
Volume 64, Issue 4 , Pages 227-234, October 2001